• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

超重和肥胖患者中新型冠状病毒2型感染的特征与转归:COVID-19大流行各波次的动态比较

Characterization and Outcomes of SARS-CoV-2 Infection in Overweight and Obese Patients: A Dynamic Comparison of COVID-19 Pandemic Waves.

作者信息

Fericean Roxana Manuela, Citu Cosmin, Manolescu Diana, Rosca Ovidiu, Bratosin Felix, Tudorache Emanuela, Oancea Cristian

机构信息

Department XIII, Discipline of Infectious Diseases, "Victor Babes" University of Medicine and Pharmacy Timisoara, Eftimie Murgu Square 2, 300041 Timisoara, Romania.

Doctoral School, ''Victor Babes'' University of Medicine and Pharmacy Timisoara, Eftimie Murgu Square 2, 300041 Timisoara, Romania.

出版信息

J Clin Med. 2022 May 21;11(10):2916. doi: 10.3390/jcm11102916.

DOI:10.3390/jcm11102916
PMID:35629042
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9143838/
Abstract

There are few data on the dynamics of SARS-CoV-2 viral manifestations in obese and overweight persons during each of the five waves that occurred in Romania during the last two years. As such, the purpose of this research was to characterize the variance in case severity, symptomatology, ICU hospitalizations, and mortality among overweight and obese individuals infected with the SARS-CoV-2 virus. We included 250 overweight and obese patients admitted to hospital with COVID-19, where 50 patients were selected from each of the five pandemic waves that existed in Romania until March 2022. A total of 113 patients with normal body mass index were included in the study. They were matched with overweight and obese patients by age, gender, and cardiovascular comorbidities to avoid the effect of confounding factors. Between the five waves of the COVID-19 pandemic in Romania, the present investigation found substantial changes in overweight and obese patient features. Obesity increases the risk of hospitalization, severe complications, and mortality from COVID-19. However, this unique demographic is disproportionately affected by obesity-related comorbidities, which contribute to these adverse outcomes. We advocate for the development of new guiding principles for the formulation of healthcare strategies aimed at high-prevalence special populations such as overweight and obese individuals, while also promoting pandemic containment and avoiding the recurrence of pandemic waves with the same guidelines that proved detrimental in terms of economic and human life loss.

摘要

关于过去两年罗马尼亚出现的五波新冠疫情期间,肥胖和超重人群中新冠病毒表现的动态数据很少。因此,本研究的目的是描述感染新冠病毒的超重和肥胖个体在病例严重程度、症状、重症监护病房住院情况及死亡率方面的差异。我们纳入了250名因新冠肺炎住院的超重和肥胖患者,其中50名患者选自罗马尼亚截至2022年3月出现的五波疫情中的每一波。该研究共纳入了113名体重指数正常的患者。通过年龄、性别和心血管合并症将他们与超重和肥胖患者进行匹配,以避免混杂因素的影响。在罗马尼亚新冠肺炎疫情的五波期间,本调查发现超重和肥胖患者的特征有显著变化。肥胖会增加新冠肺炎住院、严重并发症和死亡的风险。然而,这一独特人群受肥胖相关合并症的影响尤为严重,这些合并症导致了这些不良后果。我们主张制定新的指导原则,以制定针对超重和肥胖等高流行特殊人群的医疗保健策略,同时促进疫情防控,并避免因那些在经济和生命损失方面已证明有害的相同指导方针导致疫情浪潮再次出现。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c55/9143838/2d189845e8a1/jcm-11-02916-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c55/9143838/7e3a59c484c3/jcm-11-02916-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c55/9143838/2d189845e8a1/jcm-11-02916-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c55/9143838/7e3a59c484c3/jcm-11-02916-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c55/9143838/2d189845e8a1/jcm-11-02916-g002.jpg

相似文献

1
Characterization and Outcomes of SARS-CoV-2 Infection in Overweight and Obese Patients: A Dynamic Comparison of COVID-19 Pandemic Waves.超重和肥胖患者中新型冠状病毒2型感染的特征与转归:COVID-19大流行各波次的动态比较
J Clin Med. 2022 May 21;11(10):2916. doi: 10.3390/jcm11102916.
2
COVID-19 Clinical Features and Outcomes in Elderly Patients during Six Pandemic Waves.六次疫情浪潮期间老年患者的新冠病毒疾病临床特征及转归
J Clin Med. 2022 Nov 17;11(22):6803. doi: 10.3390/jcm11226803.
3
Burden of illness associated with overweight and obesity in patients hospitalized with COVID-19 in the United States: analysis of the premier healthcare database from April 1, 2020 to October 31, 2020.美国新冠肺炎住院患者中超重和肥胖相关的疾病负担:对2020年4月1日至2020年10月31日期间首要医疗保健数据库的分析
J Med Econ. 2023 Jan-Dec;26(1):376-385. doi: 10.1080/13696998.2023.2183679.
4
Patients with Severe Obesity during the COVID-19 Pandemic: How to Maintain an Adequate Multidisciplinary Nutritional Rehabilitation Program?新冠疫情期间的重度肥胖患者:如何维持充分的多学科营养康复计划?
Obes Facts. 2021;14(2):205-213. doi: 10.1159/000513283. Epub 2021 Mar 19.
5
SARS-CoV-2 specific immune responses in overweight and obese COVID-19 patients.超重和肥胖的 COVID-19 患者的 SARS-CoV-2 特异性免疫应答。
Front Immunol. 2023 Nov 2;14:1287388. doi: 10.3389/fimmu.2023.1287388. eCollection 2023.
6
Association of weight changes with SARS-CoV-2 infection and severe COVID-19 outcomes: A nationwide retrospective cohort study.体重变化与 SARS-CoV-2 感染和严重 COVID-19 结局的关联:一项全国性回顾性队列研究。
J Infect Public Health. 2023 Dec;16(12):1918-1924. doi: 10.1016/j.jiph.2023.10.002. Epub 2023 Oct 5.
7
Gestational diabetes mellitus and COVID-19: results from the COVID-19-Related Obstetric and Neonatal Outcome Study (CRONOS).妊娠期糖尿病与 COVID-19:COVID-19 相关产科和新生儿结局研究(CRONOS)的结果。
Am J Obstet Gynecol. 2022 Oct;227(4):631.e1-631.e19. doi: 10.1016/j.ajog.2022.05.027. Epub 2022 May 14.
8
Sociodemographic variables as predictors of adverse outcome in SARS-CoV-2 infection: an Irish hospital experience.社会人口统计学变量作为新冠病毒感染不良结局的预测因素:爱尔兰一家医院的经验
Ir J Med Sci. 2021 Aug;190(3):893-903. doi: 10.1007/s11845-020-02407-z. Epub 2020 Nov 3.
9
Clinical Characteristics and Outcomes of COVID-19 Patients with Overweight and Obesity: Turkish Nationwide Cohort Study (TurCObesity).肥胖和超重的 COVID-19 患者的临床特征和结局:土耳其全国队列研究(TurCObesity)。
Exp Clin Endocrinol Diabetes. 2022 Feb;130(2):115-124. doi: 10.1055/a-1552-4449. Epub 2021 Aug 12.
10
Obesity and COVID-19 Severity in a Designated Hospital in Shenzhen, China.肥胖与 2019 年冠状病毒病严重程度在深圳市某定点医院的相关性研究
Diabetes Care. 2020 Jul;43(7):1392-1398. doi: 10.2337/dc20-0576. Epub 2020 May 14.

引用本文的文献

1
CMV Retinitis in the Context of SARS-CoV-2 Infection: A Case Study and Comprehensive Review of Viral Interactions.2019冠状病毒病感染背景下的巨细胞病毒性视网膜炎:病例研究及病毒相互作用的全面综述
Pathogens. 2024 Oct 29;13(11):938. doi: 10.3390/pathogens13110938.
2
Evaluating Weight Loss Efficacy in Obesity Treatment with Allurion's Ingestible Gastric Balloon: A Retrospective Study Utilizing the Scale App Health Tracker.使用Allurion可吞咽胃内球囊评估肥胖治疗中的减肥效果:一项利用Scale App健康追踪器的回顾性研究。
Clin Pract. 2024 May 6;14(3):765-778. doi: 10.3390/clinpract14030061.
3
A Three-Year Cross-Sectional Analysis of Depression, Anxiety, and Quality of Life in Patients with Post-COVID-19 Syndrome.

本文引用的文献

1
Overweight and obesity as risk factors for COVID-19-associated hospitalisations and death: systematic review and meta-analysis.超重和肥胖作为2019冠状病毒病相关住院和死亡的风险因素:系统评价和荟萃分析
BMJ Nutr Prev Health. 2022 Jan 19;5(1):10-18. doi: 10.1136/bmjnph-2021-000375. eCollection 2022.
2
The Impact of Cardiovascular Risk Factors on the Course of COVID-19.心血管危险因素对新型冠状病毒肺炎病程的影响
J Clin Med. 2022 Apr 18;11(8):2250. doi: 10.3390/jcm11082250.
3
Gender Differences in the Impact of COVID-19 Pandemic on Mental Health of Italian Academic Workers.
新冠后综合征患者抑郁、焦虑及生活质量的三年横断面分析
Int J Gen Med. 2024 Mar 5;17:751-762. doi: 10.2147/IJGM.S453247. eCollection 2024.
4
A Comparative Analysis of Liver Injury Markers in Post-COVID Syndrome among Elderly Patients: A Prospective Study.老年患者新冠后综合征中肝损伤标志物的比较分析:一项前瞻性研究
J Clin Med. 2024 Feb 18;13(4):1149. doi: 10.3390/jcm13041149.
5
Non-Ventilated Patients with Spontaneous Pneumothorax or Pneumomediastinum Associated with COVID-19: Three-Year Debriefing across Five Pandemic Waves.与COVID-19相关的自发性气胸或纵隔气肿的非通气患者:跨越五个疫情波次的三年总结
J Pers Med. 2023 Oct 15;13(10):1497. doi: 10.3390/jpm13101497.
6
Post-Infection Oscillometry and Pulmonary Metrics in SARS-CoV-2 Patients: A 40-Day Follow-Up Study.新冠病毒感染患者感染后的振荡法测定与肺指标:一项40天的随访研究
Diseases. 2023 Aug 5;11(3):102. doi: 10.3390/diseases11030102.
7
Fungal Infections Identified with Multiplex PCR in Severe COVID-19 Patients during Six Pandemic Waves.在六波大流行期间,通过多重 PCR 鉴定出严重 COVID-19 患者中的真菌感染。
Medicina (Kaunas). 2023 Jul 5;59(7):1253. doi: 10.3390/medicina59071253.
8
Post-Severe-COVID-19 Cardiopulmonary Rehabilitation: A Comprehensive Study on Patient Features and Recovery Dynamics in Correlation with Workout Intensity.重度新冠后心肺康复:关于患者特征及与锻炼强度相关的恢复动态的综合研究
J Clin Med. 2023 Jun 29;12(13):4390. doi: 10.3390/jcm12134390.
9
The Impact of Therapeutic Plasma Exchange on Inflammatory Markers and Acute Phase Reactants in Patients with Severe SARS-CoV-2 Infection.治疗性血浆置换对重症 SARS-CoV-2 感染患者炎症标志物和急性期反应物的影响。
Medicina (Kaunas). 2023 Apr 29;59(5):867. doi: 10.3390/medicina59050867.
10
Acute COVID-19 Management in Heart Failure Patients: A Specific Setting Requiring Detailed Inpatient and Outpatient Hospital Care.心力衰竭患者的急性新冠肺炎管理:一种需要详细住院和门诊医院护理的特殊情况。
Biomedicines. 2023 Mar 6;11(3):790. doi: 10.3390/biomedicines11030790.
新冠疫情对意大利学术工作者心理健康影响的性别差异
J Pers Med. 2022 Apr 11;12(4):613. doi: 10.3390/jpm12040613.
4
An Imaging Overview of COVID-19 ARDS in ICU Patients and Its Complications: A Pictorial Review.ICU 患者中 COVID-19 急性呼吸窘迫综合征及其并发症的影像学概述:图文综述
Diagnostics (Basel). 2022 Mar 29;12(4):846. doi: 10.3390/diagnostics12040846.
5
The Utility of Laboratory Parameters for Cardiac Inflammation in Heart Failure Patients Hospitalized with SARS-CoV-2 Infection.实验室参数在因感染SARS-CoV-2住院的心力衰竭患者心脏炎症中的应用
Diagnostics (Basel). 2022 Mar 27;12(4):824. doi: 10.3390/diagnostics12040824.
6
The Impact of Multiplex PCR in Diagnosing and Managing Bacterial Infections in COVID-19 Patients Self-Medicated with Antibiotics.多重PCR在诊断和管理自行服用抗生素的COVID-19患者细菌感染中的作用
Antibiotics (Basel). 2022 Mar 24;11(4):437. doi: 10.3390/antibiotics11040437.
7
COVID-19 vaccine waning and effectiveness and side-effects of boosters: a prospective community study from the ZOE COVID Study.COVID-19 疫苗效力下降和加强针的有效性和副作用:来自 ZOE COVID 研究的一项前瞻性社区研究。
Lancet Infect Dis. 2022 Jul;22(7):1002-1010. doi: 10.1016/S1473-3099(22)00146-3. Epub 2022 Apr 8.
8
Using the NYHA Classification as Forecasting Tool for Hospital Readmission and Mortality in Heart Failure Patients with COVID-19.将纽约心脏协会(NYHA)分级作为预测新冠病毒病(COVID-19)心力衰竭患者再次入院和死亡率的工具
J Clin Med. 2022 Mar 2;11(5):1382. doi: 10.3390/jcm11051382.
9
Immunogenicity Following Administration of BNT162b2 and Ad26.COV2.S COVID-19 Vaccines in the Pregnant Population during the Third Trimester.第三孕期孕妇接种 BNT162b2 和 Ad26.COV2.S COVID-19 疫苗后的免疫原性。
Viruses. 2022 Feb 2;14(2):307. doi: 10.3390/v14020307.
10
Molecular Characterization of Human TMPRSS2 Protease Polymorphic Variants and Associated SARS-CoV-2 Susceptibility.人TMPRSS2蛋白酶多态性变体的分子特征及相关的SARS-CoV-2易感性
Life (Basel). 2022 Feb 3;12(2):231. doi: 10.3390/life12020231.